Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Following positive CHMP opinion, Lupin to commercialise RanluspecTM in EU throu...
The submission targets adult patients with oestrogen receptor (ER)-positive, hum...
Laboratory balance requirements across global pharmacopeias have been significa...
351(k) Biologics License Application for DRL_AB IV infusion targets rheumatoid ...
Multi-year contract to commence supplies within 4–5 months, execution planned t...
The MoU with the National Institute of Pharmaceutical Education and Research (NI...
This partnership aims to broaden VivaMed’s validation infrastructure for AI-driv...
Report highlights voltage-gated sodium channel inhibitors, pipeline trends and ...
The collaboration will combine Mayo Clinic’s Platform architecture and clinical-...
The partnership combines UNP’s AI-driven macrocycle platform with the worldwide ...
Company commemorates centenary of founder and recalls his role in building Indi...
TIQ and Austrade engage with Indian biotech, clinical trials and MedTech stakeh...
Vineet Unnikrishnan and Sonu Bhasi examine the scope of directors’ liability an...
Company signs agreement with Regeneron Pharmaceuticals and Bayer for ophthalmic...
Acquisition strengthens gynaecology portfolio and marks entry into hormone repl...
This combination, used alongside Lazcluze (lazertinib), is indicated as a first-...